Concepedia

David Digomann

DD

6

Publications

304

Citations

6

H-Index

2019

Active since

Affiliations

German Cancer Research Center(Current)

Heidelberg University

Helmholtz-Zentrum Dresden-Rossendorf

National Center for Tumor Diseases

Technische Universität Dresden

David Digomann is an author at German Cancer Research Center specializing in t cell immunity, immune regulation, and tumor immunity.

ORCID

Top concepts

Publications per year

2019–2023

6

Publications

6

The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity

David Digomann, Ina Kurth, Anna Tyutyunnykova et al. · Clinical Cancer Research · 2019 · 95 citations · Full text

SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed

David Digomann, Annett Linge, Anna Dubrovska · Autophagy · 2019 · 83 citations · Full text

LAG-3-Expressing Tumor-Infiltrating T Cells Are Associated with Reduced Disease-Free Survival in Pancreatic Cancer

Lena Seifert, Ioana Plesca, Luise Müller et al. · Cancers · 2021 · 68 citations · Full text

, , +16

TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic Cancer

Max Heiduk, Anna Klimová, Charlotte Reiche et al. · Clinical Cancer Research · 2023 · 23 citations · Full text

Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer

Max Heiduk, Ioana Plesca, Jessica M. Gluck et al. · JCI Insight · 2022 · 22 citations · Full text

Rows per page

1–5 of 6